{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:46:27Z","timestamp":1793933187194,"version":"4.8.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dysregulation of nicotinamide adenine dinucleotide (NAD\u2009+) metabolism contributes to the initiation and progression of age-associated diseases, including chronic kidney disease (CKD). Nicotinamide N-methyltransferase (NNMT), a nicotinamide (NAM) metabolizing enzyme, regulates both NAD\u2009+\u2009and methionine metabolism. Although NNMT is expressed abundantly in the kidney, its role in CKD and renal fibrosis remains unclear. We generated NNMT-deficient mice and a unilateral ureter obstruction (UUO) model and conducted two clinical studies on human CKD to investigate the role of NNMT in CKD and fibrosis. In UUO, renal NNMT expression and the degraded metabolites of NAM increased, while NAD\u2009+\u2009and NAD\u2009+\u2009precursors decreased. NNMT deficiency ameliorated renal fibrosis; mechanistically, it (1) increased the DNA methylation of connective tissue growth factor (CTGF), and (2) improved renal inflammation by increasing renal NAD\u2009+\u2009and Sirt1 and decreasing NF-\u03baB acetylation. In humans, along with CKD progression, a trend toward a decrease in serum NAD\u2009+\u2009precursors was observed, while the final NAD\u2009+\u2009metabolites were accumulated, and the level of eGFR was an independent variable for serum NAM. In addition, NNMT was highly expressed in fibrotic areas of human kidney tissues. In conclusion, increased renal NNMT expression induces NAD\u2009+\u2009and methionine metabolism perturbation and contributes to renal fibrosis.<\/jats:p>","DOI":"10.1038\/s41598-022-10476-6","type":"journal-article","created":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T18:02:33Z","timestamp":1650132153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["The significance of NAD\u2009+\u2009metabolites and nicotinamide N-methyltransferase in chronic kidney disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Rina","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoaki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Minakuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Urai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kuroita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Shigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norito","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yukioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirobumi","family":"Tokuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Wakino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,16]]},"reference":[{"key":"10476_CR1","first-page":"S1","volume":"39","author":"K\/DOQI clinical practice guidelines for chronic kidney disease","year":"2002","unstructured":"K\/DOQI clinical practice guidelines for chronic kidney disease. evaluation, classification, and stratification. Am. J. Kidney Dis. 39, S1-266 (2002).","journal-title":"Am. J. Kidney Dis."},{"key":"10476_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0272-6386(03)00372-x","volume":"41","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak, M. J. Cardiovascular complications in chronic kidney disease. Am. J. Kidney Dis. 41, 11\u201317. https:\/\/doi.org\/10.1016\/s0272-6386(03)00372-x (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"10476_CR3","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2016.10924","volume":"316","author":"M Afkarian","year":"2016","unstructured":"Afkarian, M. et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988\u20132014. JAMA 316, 602\u2013610 (2016).","journal-title":"JAMA"},{"key":"10476_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","volume":"27","author":"L Rajman","year":"2018","unstructured":"Rajman, L., Chwalek, K. & Sinclair, D. A. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 27, 529\u2013547 (2018).","journal-title":"Cell Metab."},{"key":"10476_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2013.06.016","volume":"154","author":"L Mouchiroud","year":"2013","unstructured":"Mouchiroud, L. et al. The NAD(+)\/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154, 430\u2013441. https:\/\/doi.org\/10.1016\/j.cell.2013.06.016 (2013).","journal-title":"Cell"},{"key":"10476_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","volume":"22","author":"C Canto","year":"2015","unstructured":"Canto, C., Menzies, K. J. & Auwerx, J. NAD(+) metabolism and the control of energy homeostasis: A balancing act between mitochondria and the nucleus. Cell Metab. 22, 31\u201353. https:\/\/doi.org\/10.1016\/j.cmet.2015.05.023 (2015).","journal-title":"Cell Metab."},{"key":"10476_CR7","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","volume":"15","author":"C Cant\u00f3","year":"2012","unstructured":"Cant\u00f3, C. et al. The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 15, 838\u2013847. https:\/\/doi.org\/10.1016\/j.cmet.2012.04.022 (2012).","journal-title":"Cell Metab."},{"key":"10476_CR8","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cmet.2018.03.018","volume":"27","author":"L Liu","year":"2018","unstructured":"Liu, L. et al. Quantitative analysis of NAD synthesis-breakdown fluxes. Cell Metab. 27, 1067-1080.e5. https:\/\/doi.org\/10.1016\/j.cmet.2018.03.018 (2018).","journal-title":"Cell Metab."},{"key":"10476_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/ki.2015.157","volume":"88","author":"S Wakino","year":"2015","unstructured":"Wakino, S., Hasegawa, K. & Itoh, H. Sirtuin and metabolic kidney disease. Kidney Int. 88, 691\u2013698. https:\/\/doi.org\/10.1038\/ki.2015.157 (2015).","journal-title":"Kidney Int."},{"key":"10476_CR10","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/nm.3363","volume":"19","author":"K Hasegawa","year":"2013","unstructured":"Hasegawa, K. et al. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat. Med. 19, 1496\u20131504 (2013).","journal-title":"Nat. Med."},{"key":"10476_CR11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.63.s84.36.x","author":"B Rutkowski","year":"2003","unstructured":"Rutkowski, B. et al. N-methyl-2-pyridone-5-carboxamide: a novel uremic toxin?. Kidney Int. https:\/\/doi.org\/10.1046\/j.1523-1755.63.s84.36.x (2003).","journal-title":"Kidney Int."},{"key":"10476_CR12","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1681\/ASN.2011121175","volume":"23","author":"F Duranton","year":"2012","unstructured":"Duranton, F. et al. Normal and pathologic concentrations of uremic toxins. J. Am. Soc. Nephrol. 23, 1258\u20131270 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"10476_CR13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nchembio.1204","volume":"9","author":"OA Ulanovskaya","year":"2013","unstructured":"Ulanovskaya, O. A., Zuhl, A. M. & Cravatt, B. F. NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nat. Chem. Biol. 9, 300\u2013306. https:\/\/doi.org\/10.1038\/nchembio.1204 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"10476_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nature13198","volume":"508","author":"D Kraus","year":"2014","unstructured":"Kraus, D. et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature 508, 258\u2013262. https:\/\/doi.org\/10.1038\/nature13198 (2014).","journal-title":"Nature"},{"key":"10476_CR15","doi-asserted-by":"publisher","first-page":"8637","DOI":"10.1038\/s41598-018-26882-8","volume":"8","author":"M Komatsu","year":"2018","unstructured":"Komatsu, M. et al. NNMT activation can contribute to the development of fatty liver disease by modulating the NAD+metabolism. Sci. Rep. 8, 8637. https:\/\/doi.org\/10.1038\/s41598-018-26882-8 (2018).","journal-title":"Sci. Rep."},{"key":"10476_CR16","doi-asserted-by":"publisher","first-page":"14835","DOI":"10.1016\/S0021-9258(17)36700-5","volume":"269","author":"S Aksoy","year":"1994","unstructured":"Aksoy, S., Szumlanski, C. L. & Weinshilboum, R. M. Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. J. Biol. Chem. 269, 14835\u201314840 (1994).","journal-title":"J. Biol. Chem."},{"key":"10476_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8110339","author":"A Lenglet","year":"2016","unstructured":"Lenglet, A. et al. N-methyl-2-pyridone-5-carboxamide (2PY)-major metabolite of nicotinamide: An update on an old uremic toxin. Toxins. https:\/\/doi.org\/10.3390\/toxins8110339 (2016).","journal-title":"Toxins."},{"key":"10476_CR18","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1093\/ndt\/gft071","volume":"28","author":"GJ Becker","year":"2013","unstructured":"Becker, G. J. & Hewitson, T. D. Animal models of chronic kidney disease: useful but not perfect. Nephrol. Dial. Transplant. 28, 2432\u20132438 (2013).","journal-title":"Nephrol. Dial. Transplant."},{"key":"10476_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ddmod.2010.08.002","volume":"7","author":"H-C Yang","year":"2010","unstructured":"Yang, H.-C., Zuo, Y. & Fogo, A. B. Models of chronic kidney disease. Drug Discov. Today Dis. Model. 7, 13\u201319. https:\/\/doi.org\/10.1016\/j.ddmod.2010.08.002 (2010).","journal-title":"Drug Discov. Today Dis. Model."},{"issue":"3","key":"10476_CR20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2337\/db18-0780","volume":"68","author":"S Brachs","year":"2018","unstructured":"Brachs, S. et al. Genetic nicotinamide N-methyltransferase (Nnmt) deficiency in male mice improves insulin sensitivity in diet-induced obesity but does not affect glucose tolerance. Diabetes 68(3), 527\u2013542 (2018).","journal-title":"Diabetes"},{"key":"10476_CR21","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.3892\/mmr.2014.2067","volume":"9","author":"H Zhang","year":"2014","unstructured":"Zhang, H. et al. Correlation of CTGF gene promoter methylation with CTGF expression in type 2 diabetes mellitus with or without nephropathy. Mol. Med. Rep. 9, 2138\u20132144 (2014).","journal-title":"Mol. Med. Rep."},{"key":"10476_CR22","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1097\/01.asn.0000130564.75008.f5","volume":"15","author":"V Esteban","year":"2004","unstructured":"Esteban, V. et al. Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J. Am. Soc. Nephrol. 15, 1514\u20131529. https:\/\/doi.org\/10.1097\/01.asn.0000130564.75008.f5 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"10476_CR23","doi-asserted-by":"publisher","first-page":"17329","DOI":"10.1038\/s41598-018-35339-x","volume":"8","author":"J Bi","year":"2018","unstructured":"Bi, J. et al. A downstream molecule of 1,25-dihydroxyvitamin D3, alpha-1-acid glycoprotein, protects against mouse model of renal fibrosis. Sci. Rep. 8, 17329. https:\/\/doi.org\/10.1038\/s41598-018-35339-x (2018).","journal-title":"Sci. Rep."},{"key":"10476_CR24","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","volume":"23","author":"F Yeung","year":"2004","unstructured":"Yeung, F. et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369\u20132380. https:\/\/doi.org\/10.1038\/sj.emboj.7600244 (2004).","journal-title":"EMBO J."},{"key":"10476_CR25","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jnutbio.2015.06.006","volume":"26","author":"PK Bagul","year":"2015","unstructured":"Bagul, P. K., Deepthi, N., Sultana, R. & Banerjee, S. K. Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3. J. Nutr. Biochem. 26, 1298\u20131307 (2015).","journal-title":"J. Nutr. Biochem."},{"key":"10476_CR26","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1161\/CIRCRESAHA.107.164558","volume":"102","author":"O Vakhrusheva","year":"2008","unstructured":"Vakhrusheva, O. et al. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ. Res. 102, 703\u2013710. https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.164558 (2008).","journal-title":"Circ. Res."},{"key":"10476_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-24257-7","volume":"8","author":"Y Miyasato","year":"2018","unstructured":"Miyasato, Y. et al. Sirtuin 7 deficiency ameliorates cisplatin-induced acute kidney injury through regulation of the inflammatory response. Sci. Rep. 8, 1\u201314 (2018).","journal-title":"Sci. Rep."},{"key":"10476_CR28","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","volume":"24","author":"S Imai","year":"2014","unstructured":"Imai, S. & Guarente, L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 24, 464\u2013471. https:\/\/doi.org\/10.1016\/j.tcb.2014.04.002 (2014).","journal-title":"Trends Cell Biol."},{"key":"10476_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang, H. M. et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat. Med. 21, 37 (2015).","journal-title":"Nat. Med."},{"key":"10476_CR30","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1681\/ASN.2017111218","volume":"29","author":"M Morigi","year":"2018","unstructured":"Morigi, M., Perico, L. & Benigni, A. Sirtuins in renal health and disease. J. Am. Soc. Nephrol. 29, 1799\u20131809 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"10476_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.celrep.2019.03.024","volume":"27","author":"H Muraoka","year":"2019","unstructured":"Muraoka, H. et al. Role of Nampt-Sirt6 axis in renal proximal tubules in extracellular matrix deposition in diabetic nephropathy. Cell Rep. 27, 199-212.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.024 (2019).","journal-title":"Cell Rep."},{"key":"10476_CR32","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1681\/ASN.2020081188","volume":"32","author":"I Yasuda","year":"2021","unstructured":"Yasuda, I. et al. Pre-emptive short-term nicotinamide mononucleotide treatment in a mouse model of diabetic nephropathy. J. Am. Soc. Nephrol. 32, 1355\u20131370. https:\/\/doi.org\/10.1681\/ASN.2020081188 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"10476_CR33","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1111\/jcmm.14285","volume":"23","author":"M Zheng","year":"2019","unstructured":"Zheng, M. et al. Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation. J. Cell Mol. Med. 23, 3995\u20134004. https:\/\/doi.org\/10.1111\/jcmm.14285 (2019).","journal-title":"J. Cell Mol. Med."},{"key":"10476_CR34","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000510943","volume":"7","author":"X Zhen","year":"2021","unstructured":"Zhen, X. et al. Nicotinamide supplementation attenuates renal interstitial fibrosis via boosting the activity of sirtuins. Kidney Dis. (Basel) 7, 186\u2013199. https:\/\/doi.org\/10.1159\/000510943 (2021).","journal-title":"Kidney Dis. (Basel)"},{"key":"10476_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41581-019-0216-6","volume":"16","author":"KM Ralto","year":"2020","unstructured":"Ralto, K. M., Rhee, E. P. & Parikh, S. M. NAD(+) homeostasis in renal health and disease. Nat. Rev. Nephrol. 16, 99\u2013111. https:\/\/doi.org\/10.1038\/s41581-019-0216-6 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"10476_CR36","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1681\/ASN.2015070835","volume":"27","author":"R Korstanje","year":"2016","unstructured":"Korstanje, R. et al. Loss of kynurenine 3-mono-oxygenase causes proteinuria. J. Am. Soc. Nephrol. 27, 3271\u20133277 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"10476_CR37","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/ndt\/gfn739","volume":"24","author":"JC Schefold","year":"2009","unstructured":"Schefold, J. C. et al. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Nephrol. Dial Trans. 24, 1901\u20131908. https:\/\/doi.org\/10.1093\/ndt\/gfn739 (2009).","journal-title":"Nephrol. Dial Trans."},{"key":"10476_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bcp.2017.11.007","volume":"147","author":"H Neelakantan","year":"2018","unstructured":"Neelakantan, H. et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochem. Pharmacol. 147, 141\u2013152. https:\/\/doi.org\/10.1016\/j.bcp.2017.11.007 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"10476_CR39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1124\/dmd.112.049734","volume":"41","author":"AM Real","year":"2013","unstructured":"Real, A. M., Hong, S. & Pissios, P. Nicotinamide N-oxidation by CYP2E1 in human liver microsomes. Drug Metab. Dispos. 41, 550\u2013553. https:\/\/doi.org\/10.1124\/dmd.112.049734 (2013).","journal-title":"Drug Metab. Dispos."},{"key":"10476_CR40","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3390\/ijms22031145","volume":"22","author":"F Hayat","year":"2021","unstructured":"Hayat, F. et al. The biochemical pathways of nicotinamide-derived pyridones. Int. J. Mol. Sci. 22, 1145. https:\/\/doi.org\/10.3390\/ijms22031145 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"10476_CR41","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/15257770.2014.889303","volume":"33","author":"I Pelikant-Malecka","year":"2014","unstructured":"Pelikant-Malecka, I., Sielicka, A., Kaniewska, E., Smolenski, R. T. & Slominska, E. M. 4-Pyridone-3-carboxamide-1beta-D-ribonucleoside metabolism in endothelial cells and its impact on cellular energetic balance. Nucleosides, Nucleotides Nucleic Acids 33, 338\u2013341. https:\/\/doi.org\/10.1080\/15257770.2014.889303 (2014).","journal-title":"Nucleosides, Nucleotides Nucleic Acids"},{"key":"10476_CR42","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.3390\/ijms19124055","volume":"19","author":"FZ Kadayifci","year":"2018","unstructured":"Kadayifci, F. Z., Zheng, S. & Pan, Y. X. Molecular mechanisms underlying the link between diet and DNA Methylation. Int. J. Mol. Sci. 19, 4055. https:\/\/doi.org\/10.3390\/ijms19124055 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"10476_CR43","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.1158\/0008-5472.CAN-06-4567","volume":"67","author":"R Kikuchi","year":"2007","unstructured":"Kikuchi, R. et al. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. Can. Res. 67, 7095\u20137105. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-4567 (2007).","journal-title":"Can. Res."},{"key":"10476_CR44","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/biof.30","volume":"35","author":"I Cicha","year":"2009","unstructured":"Cicha, I. & Goppelt-Struebe, M. Connective tissue growth factor: context-dependent functions and mechanisms of regulation. BioFactors 35, 200\u2013208. https:\/\/doi.org\/10.1002\/biof.30 (2009).","journal-title":"BioFactors"},{"issue":"16","key":"10476_CR45","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","volume":"15","author":"M Kato","year":"2019","unstructured":"Kato, M. & Natarajan, R. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nat. Rev. Nephrol. 15(16), 327\u2013345 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"10476_CR46","doi-asserted-by":"publisher","first-page":"366","DOI":"10.4161\/epi.27161","volume":"9","author":"LJ Smyth","year":"2014","unstructured":"Smyth, L. J., McKay, G. J., Maxwell, A. P. & McKnight, A. J. DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease. Epigenetics 9, 366\u2013376 (2014).","journal-title":"Epigenetics"},{"key":"10476_CR47","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/ndt\/gft537","volume":"29","author":"MR Wing","year":"2014","unstructured":"Wing, M. R. et al. DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study. Nephrol. Dial. Trans. 29, 864\u2013872 (2014).","journal-title":"Nephrol. Dial. Trans."},{"key":"10476_CR48","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1681\/ASN.2010060633","volume":"21","author":"G Sun","year":"2010","unstructured":"Sun, G. et al. Epigenetic histone methylation modulates fibrotic gene expression. J. Am. Soc. Nephrol. 21, 2069\u20132080. https:\/\/doi.org\/10.1681\/ASN.2010060633 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"10476_CR49","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2353\/ajpath.2007.061199","volume":"171","author":"B Lange-Sperandio","year":"2007","unstructured":"Lange-Sperandio, B. et al. Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. Am. J. Pathol. 171, 861\u2013871. https:\/\/doi.org\/10.2353\/ajpath.2007.061199 (2007).","journal-title":"Am. J. Pathol."},{"key":"10476_CR50","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/ncpneph0418","volume":"3","author":"AM Krensky","year":"2007","unstructured":"Krensky, A. M. & Ahn, Y. T. Mechanisms of disease: regulation of RANTES (CCL5) in renal disease. Nat. Clin. Pract. Nephrol. 3, 164\u2013170. https:\/\/doi.org\/10.1038\/ncpneph0418 (2007).","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"10476_CR51","doi-asserted-by":"publisher","first-page":"F622","DOI":"10.1152\/ajprenal.90566.2008","volume":"296","author":"J Kim","year":"2009","unstructured":"Kim, J. et al. Role of cytosolic NADP+-dependent isocitrate dehydrogenase in ischemia-reperfusion injury in mouse kidney. Am. J. Physiol. Renal Physiol. 296, F622-633. https:\/\/doi.org\/10.1152\/ajprenal.90566.2008 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10476_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22439","volume":"34","author":"RJ Mistry","year":"2020","unstructured":"Mistry, R. J., Klamt, F., Ramsden, D. B. & Parsons, R. B. Nicotinamide N-methyltransferase expression in SH-SY5Y human neuroblastoma cells decreases oxidative stress. J. Biochem. Mol. Toxicol. 34, e22439. https:\/\/doi.org\/10.1002\/jbt.22439 (2020).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10476_CR53","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/j.1523-1755.2002.kid558.x","volume":"62","author":"H Kumagai","year":"2002","unstructured":"Kumagai, H. et al. Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia. Kidney Int. 62, 1219\u20131228. https:\/\/doi.org\/10.1111\/j.1523-1755.2002.kid558.x (2002).","journal-title":"Kidney Int."},{"key":"10476_CR54","doi-asserted-by":"publisher","first-page":"17095","DOI":"10.1073\/pnas.262658999","volume":"99","author":"L Tremolizzo","year":"2002","unstructured":"Tremolizzo, L. et al. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc. Natl. Acad. Sci. USA 99, 17095\u201317100. https:\/\/doi.org\/10.1073\/pnas.262658999 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10476_CR55","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nchembio.1352","volume":"9","author":"K Schmeisser","year":"2013","unstructured":"Schmeisser, K. et al. Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide. Nat. Chem. Biol. 9, 693\u2013700. https:\/\/doi.org\/10.1038\/nchembio.1352 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"10476_CR56","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00125-014-3490-7","volume":"58","author":"A Kannt","year":"2015","unstructured":"Kannt, A. et al. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. Diabetologia 58, 799\u2013808. https:\/\/doi.org\/10.1007\/s00125-014-3490-7 (2015).","journal-title":"Diabetologia"},{"key":"10476_CR57","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.freeradbiomed.2015.10.414","volume":"89","author":"Y Tanaka","year":"2015","unstructured":"Tanaka, Y. et al. 1-Methylnicotinamide ameliorates lipotoxicity-induced oxidative stress and cell death in kidney proximal tubular cells. Free Radic. Biol. Med. 89, 831\u2013841. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.10.414 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"10476_CR58","doi-asserted-by":"publisher","first-page":"F707","DOI":"10.1152\/ajprenal.90240.2008","volume":"295","author":"A Vidyasagar","year":"2008","unstructured":"Vidyasagar, A., Reese, S., Acun, Z., Hullett, D. & Djamali, A. HSP27 is involved in the pathogenesis of kidney tubulointerstitial fibrosis. Am. J. Physiol.-Renal Physiol. 295, F707\u2013F716 (2008).","journal-title":"Am. J. Physiol.-Renal Physiol."},{"key":"10476_CR59","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1538\/expanim.60.481","volume":"60","author":"S Kawai","year":"2011","unstructured":"Kawai, S., Takagi, Y., Kaneko, S. & Kurosawa, T. Effect of three types of mixed anesthetic agents alternate to ketamine in mice. Exp. Anim. 60, 481\u2013487 (2011).","journal-title":"Exp. Anim."},{"key":"10476_CR60","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1534\/genetics.110.117002","volume":"186","author":"ID Carbery","year":"2010","unstructured":"Carbery, I. D. et al. Targeted genome modification in mice using zinc-finger nucleases. Genetics 186, 451\u2013459 (2010).","journal-title":"Genetics"},{"key":"10476_CR61","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1126\/science.8235655","volume":"262","author":"EL Delwart","year":"1993","unstructured":"Delwart, E. L. et al. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 262, 1257\u20131261 (1993).","journal-title":"Science"},{"key":"10476_CR62","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S1734-1140(12)70777-6","volume":"64","author":"S Ch\u0142opicki","year":"2012","unstructured":"Ch\u0142opicki, S. et al. Single bout of endurance exercise increases NNMT activity in the liver and MNA concentration in plasma; the role of IL-6. Pharmacol. Rep. 64, 369\u2013376 (2012).","journal-title":"Pharmacol. Rep."},{"key":"10476_CR63","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/ki.2013.243","volume":"84","author":"KM Andrassy","year":"2013","unstructured":"Andrassy, K. M. Comments on \u201cKDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease\u201d. Kidney Int. 84, 622\u2013623. https:\/\/doi.org\/10.1038\/ki.2013.243 (2013).","journal-title":"Kidney Int."},{"key":"10476_CR64","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1515\/cclm-2014-0578","volume":"53","author":"J Bjork","year":"2015","unstructured":"Bjork, J. et al. Accuracy of GFR estimating equations combining standardized cystatin C and creatinine assays: a cross-sectional study in Sweden. Clin. Chem. Lab. Med. 53, 403\u2013414. https:\/\/doi.org\/10.1515\/cclm-2014-0578 (2015).","journal-title":"Clin. Chem. Lab. Med."},{"key":"10476_CR65","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1161\/CIR.0000000000000242","volume":"132","author":"HR Black","year":"2015","unstructured":"Black, H. R. et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task Force 6: Hypertension: A scientific statement from the American heart association and the American college of cardiology. Circulation 132, e298-302. https:\/\/doi.org\/10.1161\/CIR.0000000000000242 (2015).","journal-title":"Circulation"},{"key":"10476_CR66","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/hr.2014.20","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto, K. et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2014). Hypertens. Res.: Offi. J. Japan. Soc. Hypertens. 37, 253\u2013390. https:\/\/doi.org\/10.1038\/hr.2014.20 (2014).","journal-title":"Hypertens. Res.: Offi. J. Japan. Soc. Hypertens."},{"key":"#cr-split#-10476_CR67.1","unstructured":"Gillett, M. J. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 2009"},{"key":"#cr-split#-10476_CR67.2","doi-asserted-by":"crossref","unstructured":"32(7): 1327-1334. Clin. Biochem. Rev. 30, 197-200 (2009).","DOI":"10.1111\/j.0954-6820.1975.tb06478.x"},{"issue":"12","key":"10476_CR68","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1080\/15257770.2011.596496","volume":"30","author":"H Yamanaka","year":"2011","unstructured":"Yamanaka, H. Japanese guideline for the management of hyperuricemia and gout. Nucleosides, Nucleotides Nucleic Acids 30(12), 1018\u20131029. https:\/\/doi.org\/10.1080\/15257770.2011.596496 (2011).","journal-title":"Nucleosides, Nucleotides Nucleic Acids"},{"key":"10476_CR69","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/ki.2015.291","volume":"89","author":"T Irifuku","year":"2016","unstructured":"Irifuku, T. et al. Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression. Kidney Int. 89, 147\u2013157 (2016).","journal-title":"Kidney Int."},{"key":"10476_CR70","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1681\/ASN.2014111136","volume":"27","author":"R Mohamed","year":"2016","unstructured":"Mohamed, R. et al. Low-Dose IL-17 therapy prevents and reverses diabetic nephropathy, metabolic syndrome, and associated organ fibrosis. J. Am. Soc. Nephrol. 27, 745\u2013765. https:\/\/doi.org\/10.1681\/ASN.2014111136 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"10476_CR71","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1681\/ASN.2016080840","volume":"28","author":"HH Chi","year":"2017","unstructured":"Chi, H. H. et al. IL-36 signaling facilitates activation of the NLRP3 inflammasome and IL-23\/IL-17 axis in renal inflammation and fibrosis. J. Am. Soc. Nephrol. 28, 2022\u20132037. https:\/\/doi.org\/10.1681\/ASN.2016080840 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"10476_CR72","doi-asserted-by":"publisher","DOI":"10.4161\/biom.27993","author":"C Rentsch","year":"2014","unstructured":"Rentsch, C., Schneiders, W., Manthey, S., Rentsch, B. & Rammelt, S. Comprehensive histological evaluation of bone implants. Biomatter https:\/\/doi.org\/10.4161\/biom.27993 (2014).","journal-title":"Biomatter"},{"key":"10476_CR73","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.2215\/CJN.00800208","volume":"3","author":"M Chonchol","year":"2008","unstructured":"Chonchol, M. et al. Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 3, 1296\u20131300. https:\/\/doi.org\/10.2215\/CJN.00800208 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10476_CR74","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","volume":"27","author":"J Yoshino","year":"2018","unstructured":"Yoshino, J., Baur, J. A. & Imai, S. I. NAD(+) intermediates: The biology and therapeutic potential of NMN and NR. Cell Metab. 27, 513\u2013528. https:\/\/doi.org\/10.1016\/j.cmet.2017.11.002 (2018).","journal-title":"Cell Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10476-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10476-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10476-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:21:16Z","timestamp":1669342876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10476-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,16]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10476"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-10476-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,16]]},"assertion":[{"value":"1 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Tomohiro Kuroita, Shuhei Shigaki, Tasuku Tsukamoto, Naoko Higuchi, Minoru Ikeda, Risa Yamanaka, Norito Yoshimura, Takashi Ono, and Hideo Yukioka are employees of Shionogi & Co., Ltd. All other authors have no competing\/conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6398"}}